These benefits, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 help the thought of concentrating on ACKR3 as a novel solution to modulate the opioid system, which could open new therapeutic avenues for opioid-linked C